(MedPage Today) — Heart attack patients gained faster control of LDL cholesterol starting PCSK9 inhibitor therapy immediately in the cath lab, the AMUNDSEN trial showed, while a clinical benefit could not be proven.
High-risk patients with acute…
Source link
Ad Banner
Show Comments (0)
Hide Comments (0)
Subscribe
Login
0 Comments
Oldest
